MENU

RGEN Repligen Corp Forecast, Technical & Fundamental Analysis

a developer of biologic drugs

RGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
RGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RGEN is expected to report earnings to rise 16.64% to 32 cents per share on July 30

Repligen Corp RGEN Stock Earnings Reports
Q2'24
Est.
$0.33
Q1'24
Missed
by $0.02
Q4'23
Est.
$0.33
Q3'23
Beat
by $0.07
Q2'23
Beat
by $0.05
The last earnings report on May 01 showed earnings per share of 28 cents, missing the estimate of 30 cents. With 458.15K shares outstanding, the current market capitalization sits at 10.26B.
A.I. Advisor
published General Information

General Information

a developer of biologic drugs

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QID41.850.91
+2.22%
ProShares UltraShort QQQ
FMAR40.38-0.06
-0.14%
FT Cboe Vest US Equity Buffer ETF Mar
JEPQ52.48-0.57
-1.07%
JPMorgan Nasdaq Equity Premium Inc ETF
JIG62.59-0.70
-1.11%
JPMorgan International Growth ETF
MAXI26.54-0.63
-2.32%
Simplify Bitcoin Strategy PLUS Inc ETF

RGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
+0.70%
DHR - RGEN
67%
Closely correlated
+1.63%
CRL - RGEN
59%
Loosely correlated
-0.27%
WAT - RGEN
59%
Loosely correlated
+1.63%
TMO - RGEN
58%
Loosely correlated
+3.44%
A - RGEN
54%
Loosely correlated
+0.61%
More